Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oragenics, a bio pharmaceutical company focused primarily on oral health products and novel antibiotics, has recieved patent number 7931892 from the United States Patent and Trademark office (USPTO) for its ProBiora3.
Subscribe to our email newsletter
ProBiora3 contains three strains of beneficial oral bacteria that help in maintaining a healthy microbial balance in the mouth.
Issuance of the patent enables Oragenics to immediately pursue label and licensing opportunities in major product categories such as food and beverage, health and wellness, pet care and nutrition.
ProBiora3 technologys is available in Oragenics’ line of probiotic products for oral care for the entire family including EvoraPro, EvoraPlus, EvoraKids, EvoraPet and Teddy’s Pride.
ProBiora3 addresses oral care issues like bad breath and stained teeth.
It can be used as an ingredient in foods, treats and products with diverse delivery systems.
Oragenics Sales and Marketing executive vice president Gerry David said ProBiora3 has the potential to the consumer packaged goods industry as consumers are becoming increasingly familiar with probiotic products and their health benefits.